帕金森病中的kynurenine通路:病理生理学作用和治疗干预措施
Aganta Chakraborty1, Priya Chaudhary2, Joy Das3
1Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal, 711316, India.
Inflammopharmacology
|November 26, 2025
概括
帕金森病涉及代谢干扰,特别是在金氨酸通路 (KP) 中. 准KP可能为早期发现帕金森病提供新的治疗方法和生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 代谢途径 代谢途径
- 神经退行性疾病的神经退行性疾病
背景情况:
- 帕金森病 (PD) 的特点是多巴胺神经元损失,α-synuclein聚合和神经炎症.
- 由于其代谢物的干扰,金氨酸通路 (KP) 参与了PD的发病过程.
- 在PD中观察到神经毒性氨酸 (QUIN) 的增加和神经保护性氨酸 (KYNA) 的减少.
研究的目的:
- 审查目前关于金氨酸途径在帕金森病中的作用的研究结果.
- 突出KP调节器和生物标志物在PD治疗和早期检测方面的潜力.
主要方法:
- 对调查帕金森病中金氨酸途径的研究进行文献综述.
- 分析代谢变化及其与PD进展的相关性.
主要成果:
- 干扰金氨酸通路有助于PD的发展.
- 氨酸 (KYNA) 和氨酸 (QUIN) 的不平衡会促进神经炎症和兴奋毒性.
- KP组件显示出作为预后指标和治疗目标的潜力.
结论:
- 调节 kynurenine 途径为帕金森病提供了新的治疗策略.
- 对KP生物标志物的进一步研究对于早期查和改善患者护理至关重要.
关键词:
生物标志物 生物标志物KP 的代谢物 KP 的代谢物.氨酸是什么 氨酸是什么基诺氨酸是什么 基诺氨酸是什么神经炎症是一种神经炎症.神经毒性 神经毒性帕金森病是帕金森氏症的一种疾病.奎诺林酸是一种酸.这就是ROSOS ROS.更多相关视频
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
3.7K
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.9K
相关概念视频
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Biosynthesis of Nucleic Acids
932
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
932
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
